160 related articles for article (PubMed ID: 8406436)
1. Long range restriction map of the von Hippel-Lindau gene region on human chromosome 3p.
Szymanski SC; Hummerich H; Latif F; Lerman MI; Röhrborn G; Schröder E
Hum Genet; 1993 Oct; 92(3):282-8. PubMed ID: 8406436
[TBL] [Abstract][Full Text] [Related]
2. Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor gene.
Richards FM; Maher ER; Latif F; Phipps ME; Tory K; Lush M; Crossey PA; Oostra B; Enblad P; Gustavson KH
J Med Genet; 1993 Feb; 30(2):104-7. PubMed ID: 8445612
[TBL] [Abstract][Full Text] [Related]
3. Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3.
Hosoe S; Brauch H; Latif F; Glenn G; Daniel L; Bale S; Choyke P; Gorin M; Oldfield E; Berman A
Genomics; 1990 Dec; 8(4):634-40. PubMed ID: 2276737
[TBL] [Abstract][Full Text] [Related]
4. Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis.
Maher ER; Bentley E; Yates JR; Latif F; Lerman M; Zbar B; Affara NA; Ferguson-Smith MA
Genomics; 1991 Aug; 10(4):957-60. PubMed ID: 1680799
[TBL] [Abstract][Full Text] [Related]
5. Mapping the Von Hippel-Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis.
Richards FM; Phipps ME; Latif F; Yao M; Crossey PA; Foster K; Linehan WM; Affara NA; Lerman MI; Zbar B
Hum Mol Genet; 1993 Jul; 2(7):879-82. PubMed ID: 8364570
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome.
Decker HJ; Gemmill RM; Neumann HP; Walter TA; Sandberg AA
Cancer Genet Cytogenet; 1989 Jun; 39(2):289-93. PubMed ID: 2568884
[TBL] [Abstract][Full Text] [Related]
7. Physical mapping of chromosome 3p25-p26 by fluorescence in situ hybridisation (FISH).
Phipps ME; Maher ER; Affara NA; Latif F; Leversha MA; Ferguson-Smith ME; Nakamura Y; Lerman M; Zbar B; Ferguson-Smith MA
Hum Genet; 1993 Aug; 92(1):18-22. PubMed ID: 8365722
[TBL] [Abstract][Full Text] [Related]
8. 3p involvement in a renal cell carcinoma in von Hippel-Lindau syndrome. Region of tumor breakpoint clustering on 3p?
Decker HJ; Neumann HP; Walter TA; Sandberg AA
Cancer Genet Cytogenet; 1988 Jul; 33(1):59-65. PubMed ID: 3164241
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours.
Crossey PA; Foster K; Richards FM; Phipps ME; Latif F; Tory K; Jones MH; Bentley E; Kumar R; Lerman MI
Hum Genet; 1994 Jan; 93(1):53-8. PubMed ID: 8270255
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
[TBL] [Abstract][Full Text] [Related]
11. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.
Linehan WM; Lerman MI; Zbar B
JAMA; 1995 Feb; 273(7):564-70. PubMed ID: 7837390
[No Abstract] [Full Text] [Related]
12. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.
Seizinger BR; Smith DI; Filling-Katz MR; Neumann H; Green JS; Choyke PL; Anderson KM; Freiman RN; Klauck SM; Whaley J
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2864-8. PubMed ID: 2011596
[TBL] [Abstract][Full Text] [Related]
13. Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis.
Maher ER; Bentley E; Yates JR; Barton D; Jennings A; Fellows IW; Ponder MA; Ponder BA; Benjamin C; Harris R
J Neurol Sci; 1990 Dec; 100(1-2):27-30. PubMed ID: 1982450
[TBL] [Abstract][Full Text] [Related]
14. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Farmer GE; Lamiell JM; Haines J; Yuen JW; Collins D; Majoor-Krakauer D
Nature; 1988 Mar; 332(6161):268-9. PubMed ID: 2894613
[TBL] [Abstract][Full Text] [Related]
15. Genetic linkage between von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus.
Crossey PA; Maher ER; Jones MH; Richards FM; Latif F; Phipps ME; Lush M; Foster K; Tory K; Green JS
Hum Mol Genet; 1993 Mar; 2(3):279-82. PubMed ID: 8499917
[TBL] [Abstract][Full Text] [Related]
16. Proximal 3p deletion in renal cell carcinoma cells from a patient with von Hippel-Lindau disease.
King CR; Schimke RN; Arthur T; Davoren B; Collins D
Cancer Genet Cytogenet; 1987 Aug; 27(2):345-8. PubMed ID: 3594418
[TBL] [Abstract][Full Text] [Related]
17. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
18. The isolation of a yeast artificial chromosome (YAC) contig extending for 2 megabases in the vicinity of the von Hippel Lindau disease gene.
Liu W; Piechocki M; Shridhar V; Lyles G; Song Z; Nakamura Y; Drabkin H; Vance J; Smith DI
Hum Mol Genet; 1993 Aug; 2(8):1177-82. PubMed ID: 8104627
[TBL] [Abstract][Full Text] [Related]
19. von Hippel-Lindau disease: identification of deletion mutations by pulsed-field gel electrophoresis.
Yao M; Latif F; Orcutt ML; Kuzmin I; Stackhouse T; Zhou FW; Tory K; Duh FM; Richards F; Maher E
Hum Genet; 1993 Dec; 92(6):605-14. PubMed ID: 8262521
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetics of renal cell carcinomas associated with von Hippel-Lindau disease.
Kovacs G; Emanuel A; Neumann HP; Kung HF
Genes Chromosomes Cancer; 1991 Jul; 3(4):256-62. PubMed ID: 1958591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
